Jensen N V - Department of Oncology, Odense University Hospital, Odense, DENMARK.

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 11 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

1960O Identification of Bladder Cancer Patients That Could Benefit from Early Post-Cystectomy Immunotherapy Based on Serial Circulating Tumour DNA (ctdna) Testing: Preliminary Results from the TOMBOLA Trial

J. Bjerggaard Jensen,K. Birkenkamp-Demtröder,I. Nordentoft, R.V. Milling, S.K. Körner, S.B. Brandt, M. Knudsen,G.W. Lam,L.H. Dohn,K. Fabrin,A. Carus, A. Petersen, U.N. Joensen,H. Pappot, P.S. Holt,N.V. Jensen,M. Agerbæk,L. Dyrskjot

Annals of Oncology (2024)

引用0浏览0引用

Metastatic atypical renal tumour with metanephric characteristics treated with Sunitinib

H Mohammad,K Madsen,O Graumann, A C Loya,N V Jensen,R H Dahlrot

UROLOGY CASE REPORTS（2022）

引用1浏览0WOS引用

666P Pembrolizumab (pembro) Monotherapy As First-Line Therapy in Advanced Clear Cell Renal Cell Carcinoma (ccrcc): Results after a Minimum of 41 Months of Follow-Up from KEYNOTE-427 Cohort A

D. F. McDermott,J-L. Lee,G. A. Bjarnason,J. Larkin,R. Gafanov, M. D. Kochenderfer,N. V. Jensen,F. Donskov, J. Malik,A. Poprach,S. S. Tykodi,T. Alonso-Gordoa,D. C. Cho,P. F. Geertsen,M. A. Climent Duran, C. Di Simone,H. Liu,J. Burgents,K. Rodriguez-Lopez,M. B. Atkins

Annals of oncology (2021): S691-S692

引用0浏览0引用

The Danish Bladder Cancer Database: Three Years Follow-Up

Hansen E., Larsson H., Norgaard M., Pilt A.P.,Jensen N.V.,Fabrin K., Thind P.,Jensen J.B.

European Urology Supplementsno. 2 (2018): e534

引用0浏览0引用

A Multicenter, Randomized Phase II Trial of Vinflunine and Gemcitabine Versus Carboplatin and Gemcitabine As First Line Treatment in Patients with Metastatic Urothelial Carcinoma Unfit for Cisplatin Based Chemotherapy Due to Impaired Renal Function-Vingem

K. Holmsten,N.V. Jensen,L. Sonne Mouritsen,M. Agerbæk, M.M. Kempel, R. Trepkas, O. Lahdenperä, E. Öfverholm, C. Mellnert, M. Cwikiel, E. Jonsson, C. Nilsson,C.-H. Shah,H. Johansson,Y. Brandberg,H. Von Der Maase,H. Pappot,A. Ullén

European urology Supplement（2017）

引用0浏览0引用

Urological Survey Geriatrics Re : Efficacy and Safety of Axitinib in Elderly Patients with Metastatic Renal Cell Carcinoma

H. Miyake, K. Harada, S. Ozono, M. Fujisawa,N. H. Azawi, S. M. Joergensen,N. V. Jensen, P. E. Clark, L. Lund

semanticscholar（2016）

引用0浏览0引用

103 Cancer of the kidney in elderly in Denmark, 2008–2012

N.H. Azawi, S.M. Joergensen,N.V. Jensen,L. Lund

European Urology Supplements（2015）

引用0浏览0引用

Tyrosine Kinase Inhibitor-Induced Hypertension in Patients Diagnosed with Renal Cell Carcinoma is Associated with Decreased Urinary Excretion of NO Metabolites"

Anne R. Tinning,N. V. Jensen,L. Bastholt,B. L. Jensen,K. Madsen

ACTA PHYSIOLOGICA（2015）

引用0浏览0引用

Hypertension, Neutropenia, Thrombocytopenia, Normal Sodium and Ldh Within the First 12 Weeks of Treatment As Independent Biomarkers of Outcome in Metastatic Renal Cell Carcinoma (Mrcc)

A.V. Soerensen,P.F. Geertsen,I.J. Christensen,G.G. Hermann,N.V. Jensen,K. Fode,A. Petersen,R. Sandin,F. Donskov

Annals of oncology : official journal of the European Society for Medical Oncology（2014）

引用0浏览0引用

P017 Vinflunine As Second Line Chemotherapy for Patients with Metastatic Urothelial Cancer – A Nordic Multi-Center Retrospective Study

K. Holmsten,L.H. Dohn,N.V. Jensen,C.-H. Shah,H. Pappot,A. Ullén

European urology Supplement（2013）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn